Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 8/20 | 0.50 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.45 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | HTR7 | P34969 | 1/20 | 0.40 |
| ▸ | HTR2B | P41595 | 1/20 | 0.40 |
| ▸ | HTR5A | P47898 | 1/20 | 0.40 |
| ▸ | HTR6 | P50406 | 1/20 | 0.40 |
| ▸ | RXRA | P19793 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15310220 | 0.86 | L3MBTL1 (0.46) | MRGPRX4NISCHL3MBTL1MEN1CYP1A2 | |
| SCHEMBL12600493 | 0.82 | BCHE (0.54) | BCHEMRGPRX4L3MBTL1HTR1AHTR2C | |
| SCHEMBL12600530 | 0.82 | MRGPRX4 (0.58) | BCHEMRGPRX4MEN1CYP1A2CYP3A4 | |
| SCHEMBL12600483 | 0.81 | BCHE (0.52) | BCHEMRGPRX4NISCHL3MBTL1HTR1A | |
| SCHEMBL27889645 | 0.81 | ABCB1 (0.44) | MRGPRX4NISCHL3MBTL1MEN1CYP1A2 | |
| SCHEMBL12600485 | 0.80 | MRGPRX4 (0.58) | BCHEMRGPRX4MAPT | |
| SCHEMBL683595 | 0.77 | L3MBTL1 (0.58) | NISCHL3MBTL1MEN1CYP1A2CYP3A4 | |
| SCHEMBL12600518 | 0.77 | BCHE (0.75) | BCHEMRGPRX4L3MBTL1MAPK1GYS1 | |
| SCHEMBL23419799 | 0.77 | SMN1; SMN2 (0.51) | KMT2AMAPTMAPK1 | |
| SCHEMBL22480760 | 0.76 | MRGPRX4 (0.73) | MRGPRX4MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2499112-B1 | SUBSTITUTED 3-(PHENOXYMETHYL) BENZYL AMINES AND PERSONAL CARE COMPOSITIONS | UNILEVER PLC NO 41424 (GB) | 2013-10-16 | — | — | EP | disclosed |
| US-8425885-B2 | Substituted 3-(phenoxymethyl) benzyl amines and personal care compositions | CONOPCO, INC. (US) | 2013-04-23 | — | — | US | disclosed |
| US-8425885-B2 | Substituted 3-(phenoxymethyl) benzyl amines and personal care compositions | CONOPCO, INC. (US) | 2013-04-23 | — | — | US | disclosed |
| US-20110110871-A1 | SUBSTITUTED 3-(PHENOXYMETHYL) BENZYL AMINES AND PERSONAL CARE COMPOSITIONS | CONOPCO, INC., D/B/A UNILEVER (US) | 2011-05-12 | — | — | US | disclosed |
| US-20110110871-A1 | SUBSTITUTED 3-(PHENOXYMETHYL) BENZYL AMINES AND PERSONAL CARE COMPOSITIONS | CONOPCO, INC., D/B/A UNILEVER (US) | 2011-05-12 | — | — | US | disclosed |
| WO-2011054805-A1 | SUBSTITUTED 3-(PHENOXYMETHYL) BENZYL AMINES AND PERSONAL CARE COMPOSITIONS | UNILEVER PLC (GB) | 2011-05-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110110871-A1 | SUBSTITUTED 3-(PHENOXYMETHYL) BENZYL AMINES AND PERSONAL CARE COMPOSITIONS | TYR, CUTA, BRD3 | BCHE 1155/4885MRGPRX4 3487/4885NISCH 222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.